<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Even a brief exposure to high-fat diet is inflammatory, low-fat diet is not; diet, not BMI, drives pathology]]></title><description><![CDATA[<p dir="auto">A study that is bound to further exacerbate the “controversy” of high-fat diets (HFD) vs. low-fat diets (LFD) and their role in chronic inflammatory diseases (in this case psoriasis and lung inflammation). Yet, the study findings are unequivocal. Namely, even a brief (4-day) exposure dramatically exacerbated the inflammatory response to a skin irritant and imprinted some sort of “cell memory” so that when the subjects were primed again with a skin irritant, the inflammatory response was much worse compared to subjects kept on a low-fat diet, even when the challenge was initiated long after the initial exposure to the HFD. Interestingly, it was the diet, not how obese the subjects were at the time of challenge and re-challenge, that determined the severity of the inflammatory response. Feeding the subjects increased levels of glucose did NOT induce the inflammatory response nor did it imprint the inflammatory “memory” to be reactivated at subsequent inflammatory challenge. This study may explain why many people who are of normal weight or even skinny, often develop chronic inflammatory conditions, while others, who are obese, remain symptom-free despite their elevated BMI. It is all about the diet, we truly are what we eat. And last, but not least, the study tested whether weight loss drugs of the GLP-1 agonist category (Ozempic Wegovy, Mounjaro, etc) could prevent the inflammatory response. They did not, which is yet another indication that those drugs are little more than a symptomatic treatment, with no long term benefit for the underlying issue, which once again has been found to be inflammation.</p>
<p dir="auto"><a href="https://www.nature.com/articles/s41586-026-11181-4" rel="nofollow ugc">https://www.nature.com/articles/s41586-026-11181-4</a></p>
<p dir="auto">“…</p>
<h2>Diet, not body mass, dictates disease</h2>
<p dir="auto">To distinguish the impact of diet itself from the consequences of established obesity, we used topical imiquimod (IMQ) challenge as a synchronized model of acute type 17 skin inflammation in which age-matched mice were fed either a short-term (1 week) or long-term (10 weeks) <strong>HFD (60% kcal from fat)</strong>, or a <strong>low-fat (control) diet (LFD; 10% kcal from fat)</strong>, before topical IMQ challenge<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR22" title="Fits, L. vander et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836–5845 (2009)." rel="nofollow ugc">22</a> (Fig. <a href="https://www.nature.com/articles/s41586-026-11181-4#Fig1" rel="nofollow ugc">1a</a>). Mice remained on their assigned diets throughout IMQ challenge. Measurements of serum cytokine levels before application of IMQ did not reveal significant differences between the three groups (Extended Data Fig. <a href="https://www.nature.com/articles/s41586-026-11181-4#Fig5" rel="nofollow ugc">1a</a>), although we did observe modestly increased numbers of TH17 cells and γδ T cells in the skin of mice fed a short- and long-term HFD, relative to the mice fed LFD (Extended Data Fig. <a href="https://www.nature.com/articles/s41586-026-11181-4#Fig5" rel="nofollow ugc">1b–d</a>). <strong>Both short- and long-term HFD also reduced glucose tolerance, although these effects were more pronounced in obese mice that were fed a long-term HFD</strong> (Extended Data Fig. <a href="https://www.nature.com/articles/s41586-026-11181-4#Fig6" rel="nofollow ugc">2a,b</a>).</p>
<p dir="auto">…”</p>
<p dir="auto">“…<strong>Transient exposure to HFD during a narrowly defined peri-initiation window durably reshapes tissue immunity without requiring obesity</strong>. The consequence is not merely heightened acute pathology but a lasting change in local immune responsiveness that <strong>becomes evident months later after rechallenge, after return to LFD</strong>. These experiments identify dietary state, rather than accumulated adiposity, as the proximate determinant of disease amplification. Three compositionally distinct fat-enriched diets—HFD, MFD and WD—each amplified IMQ-induced type 17 skin inflammation, whereas <strong>glucose water alone did not</strong>. Conversely, <strong>transiently switching persistently obese mice from HFD to LFD during a corresponding four-day peri-initiation window attenuated disease</strong>. Semaglutide further sharpened this dissociation: GLP-1 receptor agonism improved glucose handling, reduced body weight and adiposity, and lowered circulating insulin and leptin, but did not attenuate HFD-amplified inflammatory responses. Although longer-term treatment with GLP-1 receptor agonists and related incretin-based therapies may improve established psoriasis in patients with obesity or type 2 diabetes<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR44" title="Ciancio, G. et al. Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. Front. Immunol. 17, 1744308 (2026)." rel="nofollow ugc">44</a>,<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR45" title="Lebwohl, M. et al. Ixekizumab with or without tirzepatide in adults with psoriasis and overweight or obesity. JAMA Dermatol. 162, 709–719 (2026)." rel="nofollow ugc">45</a>,<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR46" title="Buonanno, S. et al. The potential role of GLP-1 receptor agonists in the management of psoriatic disease: a scoping review. Inflamm. Res. 74, 167 (2025)." rel="nofollow ugc">46</a>,<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR47" title="Petković-Dabić, J. et al. Effects of semaglutide treatment on psoriatic lesions in obese patients with type 2 diabetes mellitus: an open-label, randomized clinical trial. Biomolecules 15, 46 (2025)." rel="nofollow ugc">47</a>, our experiment addressed the distinct question of whether short-term <strong>semaglutide treatment</strong> blocks the additional amplification imposed by coincident HFD exposure. It <strong>did not</strong>, <strong>indicating that systemic metabolic improvement and diet-primed inflammatory susceptibility are separable</strong>. Whereas prolonged high-fat or Western-style feeding has previously been shown to exacerbate IMQ-induced and IL-23-driven inflammation<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR48" title="Higashi, Y. et al. High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice. Exp. Dermatol. 27, 178–184 (2018)." rel="nofollow ugc">48</a>,<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR49" title="Nakamizo, S. et al. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells. Sci. Rep. 7, 14076 (2017)." rel="nofollow ugc">49</a>,<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR50" title="Shi, Z. et al. Short-term western diet intake promotes IL-23-mediated skin and joint inflammation accompanied by changes to the gut microbiota in mice. J. Invest. Dermatol. 141, 1780–1791 (2021)." rel="nofollow ugc">50</a> and, with sustained exposure, promote spontaneous dermatitis<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR23" title="Shi, Z. et al. Short-term exposure to a western diet induces psoriasiform dermatitis by promoting accumulation of IL-17A-producing γδ T cells. J. Invest. Dermatol. 140, 1815–1823 (2020)." rel="nofollow ugc">23</a>,<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR24" title="Zhang, Y. et al. Epidermal fatty acid binding protein promotes skin inflammation induced by high-fat diet. Immunity 42, 953–964 (2015)." rel="nofollow ugc">24</a>, <strong>as little as 4 days at inflammatory onset was sufficient here</strong>. HFD alone did not confer durable susceptibility to a later inflammatory challenge, indicating that dietary exposure must intersect with tissue inflammation to imprint the long-term phenotype. Our findings may also help explain a previous observation that leptin-deficient <em>ob/ob</em> mice did not exhibit increased IMQ susceptibility despite profound adiposity<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR49" title="Nakamizo, S. et al. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells. Sci. Rep. 7, 14076 (2017)." rel="nofollow ugc">49</a>. As leptin supports optimal TH17 differentiation<a href="https://www.nature.com/articles/s41586-026-11181-4#ref-CR51" title="Gerriets, V. A. et al. Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity. Eur. J. Immunol. 46, 1970–1983 (2016)." rel="nofollow ugc">51</a>, its absence may limit engagement of the IL-1β–TH17 axis. Consistent with this possibility, <strong>transient peri-initiation HFD amplified IMQ-induced inflammation in WT but not <em>ob/ob</em> mice</strong> (Extended Data Fig. <a href="https://www.nature.com/articles/s41586-026-11181-4#Fig6" rel="nofollow ugc">2o</a>).”</p>
<p dir="auto"><a href="https://www.technologynetworks.com/applied-sciences/news/could-a-few-bad-dietary-choices-worsen-your-next-immune-response-417860" rel="nofollow ugc">https://www.technologynetworks.com/applied-sciences/news/could-a-few-bad-dietary-choices-worsen-your-next-immune-response-417860</a></p>
<p dir="auto">“…Scientists have long known that <strong>diet shapes the immune system</strong>. Now, a UC San Francisco team has found that <strong>even a brief dietary change can substantially change how the body responds to skin irritation</strong>, at least in mice. When scientists fed mice <strong>a high-fat diet for just a few days, the mice had a much worse reaction to an irritating cream. And the skin stayed on alert even after the mice returned to a low-fat diet and inflammation cleared, responding more strongly the next time it was exposed to the cream. The findings suggest that short-term diet may have just as much effect as body weight when it comes to inflammation</strong>. “Long-term dietary habits absolutely matter for health, but our study unearthed a much more real-time influence of diet,” said <a href="https://profiles.ucsf.edu/sagar.bapat" rel="nofollow ugc">Sagar Bapat</a>, MD, PhD, professor of pathology at UCSF and corresponding author of <a href="https://www.nature.com/articles/s41586-026-11181-4" rel="nofollow ugc">the paper, which appears in <em>Nature</em></a> on Oct. 28. “<strong>Breakfast, lunch, dinner — they all can have a tremendous and rapid impact on the immune system</strong>.”</p>
<p dir="auto">“…“For many years, we’ve known that obesity is tied to more severe inflammation. But we wanted to know whether it was <strong>the extra weight or simply the bad diet that was driving the stronger response</strong>,” Jiang said. So, the team tested whether <strong>just four days on high-fat food was enough to trigger an over-active immune response</strong>. They switched mice that had been raised on low-fat food to high-fat food, and dabbed one ear with imiquimod three days later. <strong>The normal-weight mice developed severe ear inflammation just like the obese mice</strong>. Likewise, <strong>obese mice that had been switched to normal food for four days experienced much milder inflammation</strong>. <strong>Weeks later, after the normal-weight mice had returned to a low-fat diet and their inflammation had subsided, they got a second dose of imiquimod in the same ear that had flared before — and it triggered an outsized response</strong>. Jiang and Bapat found that high-fat food drew rapid-response immune cells into the skin, where they amplified the reaction to imiquimod. As the inflammation subsided, other immune cells, called memory T cells remained in the affected ear. Together, <strong>these changes left the tissue primed for the next time</strong>. The team found a similar kind of <strong>heightened inflammation in response to irritation in the lungs after just a few days of eating a high-fat diet</strong>. “The diet of a laboratory mouse doesn’t map neatly onto what we eat, but <strong>it’s striking how quickly the immune system responds to what’s happening in the body right now</strong>,” said Jiang. “Diet, exercise, sleep — they could all shape immune health in ways we don’t yet appreciate.”</p>
<p dir="auto">Via: <a href="https://haidut.me/?p=3154" rel="nofollow ugc">https://haidut.me/?p=3154</a></p>
]]></description><link>https://bioenergetic.forum/topic/9582/even-a-brief-exposure-to-high-fat-diet-is-inflammatory-low-fat-diet-is-not-diet-not-bmi-drives-pathology</link><generator>RSS for Node</generator><lastBuildDate>Mon, 16 Nov 2026 00:08:04 GMT</lastBuildDate><atom:link href="https://bioenergetic.forum/topic/9582.rss" rel="self" type="application/rss+xml"/><pubDate>Sun, 15 Nov 2026 15:42:01 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Even a brief exposure to high-fat diet is inflammatory, low-fat diet is not; diet, not BMI, drives pathology on Sun, 15 Nov 2026 23:03:57 GMT]]></title><description><![CDATA[<p dir="auto">Several studies indicate that a dietary intake consisting of 60% fat is “detrimental” to health. <strong>Levels above 40% are often harmful</strong>. The ideal intake is between 20% and 30%.<br />
Here is an important distinction: a ketogenic diet is generally a therapeutic or goal-specific tool, not a maintenance eating pattern. That changes how the “60% fat” figure should be judged.<br />
I’ve asked AI (Claude) to find a study. Not found. Here is the answer.<br />
Goals where it is best supported<br />
•	Drug-resistant epilepsy: the strongest indication, used for about a century, especially in children.<br />
•	Short- and medium-term weight loss: effective, but its advantage over other diets tends to fade after 6 to 12 months.<br />
•	Type 2 diabetes and prediabetes: improved blood sugar and HbA1c, often with reduced medication, under medical supervision.<br />
•	Other areas (migraine, polycystic ovary syndrome, some neurological conditions): results are still preliminary.<br />
What this means for assessing risk<br />
•	The question becomes expected benefit versus risk, as with a treatment, rather than comparison with an ideal balanced diet.<br />
•	Risk depends on duration: a few weeks or months is very different from several years, for which data are scarce.<br />
•	The known side effects to monitor are raised LDL cholesterol in some people, deficiencies (fiber, magnesium, certain vitamins), digestive problems, kidney stones, and the “keto flu” at the start.<br />
•	Monitoring (lipid profile, kidney and liver function) is recommended, and some people should avoid it (pancreatitis, liver failure, certain fat-metabolism disorders, pregnancy without medical advice).<br />
Studies that find harm often follow general populations over long periods. They don’t answer the question “is it useful and acceptable for reaching a given goal over a given period?” The two kinds of evidence don’t contradict each other, because they answer different questions.<br />
<strong>Comment</strong> (LucH):<br />
So 2 points going in the same direction: <strong>inflammation and glucose intolerance</strong> when eating high fat for several days. A result in mice, not in human beings. But whenever my body reacts heavily to a high fat meal, I take lipase enzymes… I don’t wait to see if …</p>
]]></description><link>https://bioenergetic.forum/post/66775</link><guid isPermaLink="true">https://bioenergetic.forum/post/66775</guid><dc:creator><![CDATA[LucH]]></dc:creator><pubDate>Sun, 15 Nov 2026 23:03:57 GMT</pubDate></item></channel></rss>